Michael Boyiadzis MD
Assistant Professor, Medicine, University of Pittsburgh School of Medicine
Join to View Full Profile
200 Meyran AveSuite 318Pittsburgh, PA 15213
Phone+1 412-586-9874
Fax+1 412-647-4486
Are you Dr. Boyiadzis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Boyiadzis, MD is an oncologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is an Assistant Professor at University of Pittsburgh School of Medicine.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2001 - 2005
St Agnes HealthCareResidency, Internal Medicine, 1998 - 2001
University of Debrecen Medical and Health Science CenterClass of 1995
Certifications & Licensure
PA State Medical License 2004 - 2024
Publications & Presentations
PubMed
- A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.Kevin Quann, Konstantinos Lontos, Alison Sehgal, Anastasios Raptis, Annie Im
Haematologica. 2024-12-01 - 1 citationsPhase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.Annie Im, Kevin Quann, Mounzer Agha, Anastasios Raptis, Robert L Redner
American Journal of Hematology. 2024-03-01 - 7 citationsA study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.Sheng F Cai, Ying Huang, Jennie R Lance, Hsiaoyin Charlene Mao, Andrew J Dunbar
Blood Advances. 2024-01-23
Press Mentions
- DPP4+ Exosomes in AML Patients’ Plasma Suppress Proliferation of Hematopoietic Progenitor CellsNovember 2nd, 2020
